GlassScriptPhysician profile
Alexander Hernandez
NPI 1144725946
$870.95
in general payments reported to CMS, 2019-2025
19 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $51.54 · 2023: $154 · 2024: $390 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $819.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $316.37 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $82.03 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $51.54 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $49.77 | 2025 | Dojolvi |
| Exact Sciences Corporation | $43.72 | 2024 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $35.88 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.93 | 2024 | Xifaxan, Trulance |
| Amneal Pharmaceuticals LLC | $29.81 | 2024 | Unithroid |
| Abbvie INC. | $28.96 | 2024 | |
| Boston Scientific Corporation | $25.95 | 2024-2025 | Axonics |
| Dexcom, INC. | $24.63 | 2025 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $24.22 | 2025 | Aptima |
| Phadia US INC. | $22.44 | 2023 | Immunocap |
| Teleflex LLC | $20.48 | 2025 | Urolift |
| Novartis Pharmaceuticals Corporation | $18.47 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.82 | 2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $16.11 | 2024 | Airsupra |
| Abbott Laboratories | $14.42 | 2024 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $14.40 | 2025 | Vaxneuvance, Capvaxive, Rotateq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.